This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McCray, E Articles by O'Day, D Search for Related Content PubMed PubMed Citation Articles by McCray, E Articles by O'Day, D

 Previous Article  |  Next Article 

J Clin Microbiol. 1986 October; 24(4): 625-628

Outbreak of Candida parapsilosis endophthalmitis after cataract extraction and intraocular lens implantation.

ABSTRACT

Between November 1983 and January 1984, 13 cases of Candida parapsilosis endophthalmitis occurred in Florida, Georgia, and Tennessee in patients who had had an intraocular lens implantation (IOLI) or cataract extraction with an IOLI. This outbreak followed the introduction in July 1983 of a new brand of balanced salt solution (BSS) used as an intraoperative ophthalmic irrigation solution. This product was subsequently recalled because of intrinsic fungal contamination. A retrospective cohort study including 704 ophthalmology patients at risk for exposure to this brand of BSS revealed that definite exposure to that product was a significant risk factor for C. parapsilosis endophthalmitis (P less than 0.001, Fisher exact test). A retrospective case control study including 203 control patients with definite exposure to BSS suggested that exposure to systemic steroids (P = 0.007, Fisher exact test) was an additional risk factor for C. parapsilosis endophthalmitis. Treatment modalities among the 13 patients included topical, intraocular, or systemic antifungal therapy (or a combination of these modalities) in 13 patients and vitrectomy in 10 patients. No patients had systemic symptoms or complete visual loss. Laboratory investigations showed a 6.7% overall contamination of the product with C. parapsilosis. After recall of the product by the manufacturer, no patients having a cataract extraction or IOLI at the institutions studied are known to have developed C. parapsilosis endophthalmitis.

This article has been cited by other articles:

• SMITH, G. T, LIU, C. S C (2001). Is it time for a new attitude to ""simultaneous"" bilateral cataract surgery?. Br. J. Ophthalmol. 85: 1489-1496 [Full Text]  
• Klotz, S. A., Penn, C. C., Negvesky, G. J., Butrus, S. I. (2000). Fungal and Parasitic Infections of the Eye. Clin. Microbiol. Rev. 13: 662-685 [Abstract] [Full Text]